Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

- PMLiVE

Neuway appoints Boehringer’s Baiker to board

He has 25 years’ experience at German pharma company

UK flag

Pharma firms open up drug libraries to UK researchers

AZ, GSK, Janssen, Lilly, Pfizer, Takeda and UCB partner with Medical Research Council

- PMLiVE

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

Deal Watch table for June 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during June 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

The moving parts of orphan drug development

Tackling rare diseases requires high levels of cooperation, regulatory support and a determination to succeed

- PMLiVE

Amgen and Boehringer drugs win FDA breakthrough status

Leukaemia drug and Pradaxa antidote will benefit from accelerated regulatory processes

Novartis building

Novartis pulls EMA application for expanded Tasigna use

And Boehringer confirms it won't seek approval for faldaprevir as it exits hepatitis C

- PMLiVE

Biosimilar Lantus leads CHMP opinions

Boehringer and Lilly’s insulin one of six new medicines recommended for EU approval

- PMLiVE

Boehringer pulls faldaprevir and exits hepatitis C market

Unable to challenge all-oral options from Gilead and others

- PMLiVE

ADA: Empagliflozin overcomes FDA concerns

Boehringer and Lilly expect decision on diabetes treatment by end of 2014

- PMLiVE

Boehringer gets ‘kite mark’ for health information

First pharma company awarded The Information Standard Certification in UK

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links